Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.
Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C. · 2006
Read Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. by Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1563474.txt.
Description
Tiny RNA samples from needle biopsies can now be profiled in bulk. Mattie and co-authors built that method in 2006 for microRNAs, small gene regulators tied to cancer. Older methods needed far more tissue than a biopsy gives.
Their trick boosts and labels microRNAs from mere picograms, trillionths of a gram. Readings matched a standard lab method closely. In prostate biopsies, the profiles split advanced cancers from healthy tissue. In breast biopsies, they split tumor types by two key markers. Mattie shows biopsy microRNA profiles could serve as cancer biomarkers.
Catalog record
| CREATOR | Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C. |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |